1. Hameed MQ, Rotenberg A. Ceftriaxone treatment of TBI. In: Heidenreich K, editor. New therapeutics for traumatic brain injury: prevention of secondary brain damage and enhancement of repair and regeneration. 1st ed. San Diego: Elsevier Science; 2016. p. 235–49.
2. Pitkänen A, Kharatishvili I, Karhunen H, Lukasiuk K, Immonen R, Nairismägi J, et al. Epileptogenesis in experimental models. Epilepsia. 2007;48(Suppl 2):13–20.
3. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology. 2007;68(5):326–37.
4. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.
5. Wilson LD, Leath TC, Patel MB. Management of paroxysmal sympathetic hyperactivity after traumatic brain injury. In: Heidenreich K, editor. New therapeutics for traumatic brain injury: prevention of secondary brain damage and enhancement of repair and regeneration. 1st ed. San Diego: Elsevier Science; 2016. p. 145–58.